Page last updated: 2024-09-05

clorazepate dipotassium and Morbid Obesity

clorazepate dipotassium has been researched along with Morbid Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arapis, K; Augustin, P; Desmard, M; Fournier, P; Montravers, P; Ribeiro-Parenti, L	1

Other Studies

1 other study(ies) available for clorazepate dipotassium and Morbid Obesity

Article	Year
Prolonged benzodiazepine coma as a complication of morbid obesity. Obesity surgery, 2013, Volume: 23, Issue:9 Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Benzodiazepines; Clobazam; Clorazepate Dipotassium; Coma; Drug Administration Schedule; Female; France; Gastric Bypass; Glasgow Coma Scale; Humans; Middle Aged; Obesity, Morbid; Postoperative Complications; Sepsis; Treatment Outcome	2013

Article

Year

Prolonged benzodiazepine coma as a complication of morbid obesity.

Obesity surgery, 2013, Volume: 23, Issue:9

Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Benzodiazepines; Clobazam; Clorazepate Dipotassium; Coma; Drug Administration Schedule; Female; France; Gastric Bypass; Glasgow Coma Scale; Humans; Middle Aged; Obesity, Morbid; Postoperative Complications; Sepsis; Treatment Outcome

2013